Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia.
Somnuek
S
Sungkanuparph
Awachana
A
Jiamsakul
Sasisopin
S
Kiertiburanakul
Sunee
S
Sirivichayakul
Jutarat
J
Praparattanapan
Rami
R
Kantor
D000293:Adolescent; D000328:Adult; D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D001208:Asia / Q000453:epidemiology; D015331:Cohort Studies; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009570:Nitriles / Q000494:pharmacology*; D015995:Prevalence; D011743:Pyrimidines / Q000494:pharmacology*; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D000068696:Rilpivirine; D055815:Young Adult
D044966:Anti-Retroviral Agents; D009570:Nitriles; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; D000068696:Rilpivirine